Original document(34 pages)  中文版
    The invention relates to heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives as well as their physiologically compatible salts and physiologically functional derivatives. The invention concerns compounds of formula (I), wherein the radicals have the cited meanings, and the physiologically compatible salts thereof. The compounds are suited for use, e.g. as medicaments for preventing and treating type 2 diabetes.
Application Number
申请号
200580002824 Application Date
申请日
2005.01.15
Title 名称 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
Publication Number
公开号
1910181 Publication Date
公开日
2007.02.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D471/04;C07D401/12;A61K31/4375;A61K31/47;A61P3/10
Applicant(s) Name
申请人
Aventis Pharma GmbH
Address 地址
Inventor(s) Name 发明人 Defossa Elisabeth;Kadereit Dieter;Ruf Sven;Klabunde Thomas;Schmoll Dieter;Herling Andreas;Wendt Karl-ulrich
Attorney & Agent 代理人 huang gesheng zhang shuo
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.